Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate

Human Pathology(2020)10.1016/j.humpath.2020.04.014Source: DataRank Database

Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate is a research paper published in Human Pathology (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.55)OA: greenTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Michael C. Haffner ORCID,Mindy K. Graham ORCID,David Lim ORCID,Christine Davis,Eva Corey ORCID

Live enrichment

PubMed:32389660 OpenAlex:https://openalex.org/W3022650203

National Institutes of Health

Grant: 3P50CA058236-02S1

SPECIALIZED PGM OF RESEARCH EXCELLENCE/PROSTATE CANCER

National Institutes of Health

Grant: 5P30CA006973-52

PROGRAM LEADERSHIP

NCI NIH HHS

Grant: F32 CA213742

NCI NIH HHS

Grant: P30 CA006973

NCI NIH HHS

Grant: P50 CA058236

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7321874

publisherhttps://api.elsevier.com/content/article/PII:S0046817720300861?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0046817720300861?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.humpath.2020.04.014

Fields of Study

Prostate Cancer Treatment and ResearchTelomeres, Telomerase, and SenescencePARP inhibition in cancer therapy0301 basic medicine0303 health sciences03 medical and health sciencesAdenocarcinomaCarcinoma, NeuroendocrineCarcinoma, Small CellHumansMaleMiddle AgedProstatic NeoplasmsTelomere

MeSH Terms

AdenocarcinomaHumansMaleMiddle AgedProstatic NeoplasmsTelomereCarcinoma, NeuroendocrineCarcinoma, Small Cell

Keywords

TelomereProstateBiologyTelomeraseSmall-cell carcinomaAdenocarcinomaPathologyCarcinomaInternal medicineMedicineCancerGeneticsGeneMaleHumansProstatic NeoplasmsCarcinoma, Small CellMiddle AgedCarcinoma, NeuroendocrineNeuroendocrineProstate cancerTelomeres

Sustainable Development Goals

SDG 0: Good health and well-being